Clinical Trial Update: Pharmacokinetic Study to Compare Itepekimab Exposure When Administered With an Autoinjector Versus Prefilled Syringe [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study compares itepekimab exposure when administered with an autoinjector versus a prefilled syringe in chronic obstructive pulmona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• itepekimab (itepekimab)

Snippet

Sponsor: Sanofi | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED